Modified vaccinia virus strains for use in diagnostic and therapeutic methods
US9005602B2 · kind B2 · utility
8Cited by
84References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 2011 |
| Grant date | Apr 14, 2015 |
| Priority date | — |
| Expiry date | Nov 2, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/24162
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Modified viruses and methods for preparing the modified viruses are provided. Vaccines that contain the viruses are provided. The viruses can be used in methods of treatment of diseases, such as proliferative and inflammatory disorders, including cancer, and as anti-tumor and/or antiangiogenic agents. The viruses also can be used in diagnostic methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.